Live feed16:11:49·48dINSIDERFilingCSO & EVP, Head of Research Fitzgerald Kevin Joseph sold $417,685 worth of shares (1,291 units at $323.54), decreasing direct ownership by 6% to 20,569 units (SEC Form 4)ALNY· Alnylam Pharmaceuticals Inc.Health CareOriginal source